This site uses cookies to offer you a better browsing experience. By continuing to access the web site, you agree that we will store personal data in a cookie as outlined in our Privacy Policy, which is also accessible from the sidebar.
Sign up to save, edit, and PDF your reports and access more resources.
How to use
Make your selections on the left
Your template will build on the right
Copy/Paste into your LIS
Uh Oh! It looks like you may have forgotten a required element in your template. Please review the
highlighted selections.
Some optional elements have been omitted. You can delete this from the synoptic if you don't want to include it.
Procedure
Tumor Site
Tumor Size (cm)
Histologic Type (WHO classification)
Histologic Grade
Tumor Extension
A word about tumor extent
Margins
Choose margins examined
Distance of invasive carcinoma from closest margin (mm)
Gastrectomy margins
Proximal Margin
Distal Margin
Omental Margin
Endoscopic Resection Margins
Deep Margin
Mucosal Margin
Other margin
Treatment Effect
Lymphovascular Invasion
+ Perineural Invasion
Regional Lymph Nodes
Pathologic Staging (pTNM)
TNM Descriptors (select all that apply)
pT
pN
pM
+ Additional Pathologic Findings (select all that apply
+ Ancillary Studies:
Immunohistochemistry
Choose HER2 Testing - If performed
HER2 Testing
HER2 by immunohistochemistryHER2 - immunohistochemistry clone
HER2 by in-situ hybridizationNumber of observers:Number of invasive cancer cells counted:Average number of HER2 (ERBB2) signals per cancer cell:Average number of CEP17 signals per cancer cell:HER2 (ERBB2) - method used
HER2 by genomic testingSpecify genomic testing method